Literature DB >> 12920556

[Diagnosis and treatment of mycobacterial keratitis following LASIK. Case report and review of the literature].

M P Holzer1, K D Solomon, H P Sandoval, G U Auffarth.   

Abstract

BACKGROUND: Mycobacterial keratitis is a rare complication following LASIK but can lead to an extremely unfavourable outcome. The diagnosis and treatment is often delayed due to confusion with other entities including diffuse lamellar keratitis and poor clinical outcomes with flap amputation and/or keratoplasty are often the case. PATIENT AND METHODS: We report the results of LASIK in a 51-year-old woman with subsequent early-diagnosed mycobacterial keratitis and compared this case to treatments and outcomes reported in the literature.
RESULTS: The patient presented 10 days following LASIK with a white focal infiltrate in the stromal interface. The flap was lifted and cultures from the stromal bed and the reverse of the flap were obtained and the interface irrigated. The patient was treated with topical antibiotics (ciprofloxacin 0.3%, amikacin 2.5%, clarithromycin 40 mg/ml and tobramycin 15 mg/ml) for 8 weeks and at the most recent follow-up she had a visual acuity of 1.25.
CONCLUSION: In a large number of published cases in the literature the flap had to be amputated and/or corneal transplants were necessary. Early diagnosis and treatment however, are essential to successfully treat post-LASIK keratitis. Therefore the patients should be followed up carefully in the early postoperative period.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920556     DOI: 10.1007/s00347-003-0838-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  23 in total

1.  Refractive Surgery Survey 2001.

Authors:  Kerry D Solomon; Mike P Holzer; Helga P Sandoval; Luis G Vargas; Liliana Werner; David T Vroman; Terrance J Kasper; David J Apple
Journal:  J Cataract Refract Surg       Date:  2002-02       Impact factor: 3.351

2.  Mycobacterium interface keratitis after laser in situ keratomileusis.

Authors:  A Solomon; C L Karp; D Miller; S R Dubovy; A J Huang; W W Culbertson
Journal:  Ophthalmology       Date:  2001-12       Impact factor: 12.079

3.  Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis.

Authors:  N S Chandra; M F Torres; K L Winthrop; D A Bruckner; D G Heidemann; H M Calvet; M Yakrus; B J Mondino; G N Holland
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

4.  Lessons from a proficiency testing event for acid-fast microscopy.

Authors:  J E Hotaling; M Fitzgerald; D O'Donnell; L M Parsons; M Salfinger
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

5.  Infectious keratitis after laser refractive surgery.

Authors:  G A Kouyoumdjian; S L Forstot; V D Durairaj; R E Damiano
Journal:  Ophthalmology       Date:  2001-07       Impact factor: 12.079

6.  Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy.

Authors:  R Brancato; F Carones; E Venturi; A Cavallero; G Gesu
Journal:  Arch Ophthalmol       Date:  1997-10

7.  Corneal pharmacokinetics of topical clarithromycin.

Authors:  R H Gross; G N Holland; S J Elias; R Tuz
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-04       Impact factor: 4.799

8.  Comparison of topical antibiotics for treating Mycobacterium chelonae keratitis in a rabbit model.

Authors:  F R Hu; I J Wang
Journal:  Curr Eye Res       Date:  1998-05       Impact factor: 2.424

9.  Nontuberculous mycobacterial keratitis in south Florida.

Authors:  J G Ford; A J Huang; S C Pflugfelder; E C Alfonso; R K Forster; D Miller
Journal:  Ophthalmology       Date:  1998-09       Impact factor: 12.079

10.  Mycobacterium chelonae keratitis following laser in situ keratomileusis.

Authors:  V Reviglio; M L Rodriguez; G S Picotti; M Paradello; J D Luna; C P Juárez
Journal:  J Refract Surg       Date:  1998 May-Jun       Impact factor: 3.573

View more
  1 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.